We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

1 hedge funds and large institutions have $381 invested in Abiomed Inc in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $381 → $381 ($0)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
1
Huntington National Bank
Ohio
$381 – – –

ABMD Hedge Fund Activity: Q1 2026 in Review

1 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2026, worth a combined $381 — unchanged from a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ABMD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Abiomed Inc (ABMD) as of Q1 2026, down from 2 in Q4 2025.
  • Funds reported $381 of Abiomed Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q1 2026 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q1 2026.